Why the study?
Patients with ischemic left ventricular systolic dysfunction have poorer revascularization outcomes and represent <1% of trial participants, leaving the optimal revascularization modality unknown.
Does percutaneous coronary intervention compared to coronary artery bypass grafting improve outcomes in patients with ischemic left ventricular systolic dysfunction?
Does percutaneous coronary intervention compared to coronary artery bypass grafting improve outcomes in patients with ischemic left ventricular systolic dysfunction?
There is a lack of randomized controlled trial evidence comparing PCI and CABG in patients with ischemic left ventricular systolic dysfunction, highlighting the need for the upcoming STICH 3.0 trial.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Vervoort et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: